JESSICA WARE: Open Payments
NPI 1003921008 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 20 payments from 8 companies in 2025. Trend: 2023 $502 · 2024 $865 · 2025 $448
Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $160 |
| Amgen Inc. | 5 | $116 |
| PFIZER INC. | 3 | $68 |
| ABBVIE INC. | 1 | $24 |
| Becton, Dickinson and Company | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: Ozempic, EVENITY, PREVNAR 20, Wegovy, KRYSTEXXA, QULIPTA, BD MAX System, BD MAX Instrument, MOUNJARO.
Industry payments across VA — which companies pay providers there.
